By Ioana Patringenaru – UC San Diego Today –
Researchers have developed a new therapy that can be injected intravenously right after a heart attack to promote healing and prevent heart failure.
The therapy both prompts the immune system to encourage tissue repair and promotes survival of heart muscle cells after a heart attack. Researchers tested the therapy in rats and showed that it is effective up to five weeks after injection.
The research team, led by bioengineers at the University of California San Diego and chemists at Northwestern University, published their findings in the April 25 issue of the journal Advanced Materials.
